Based on this, the pathogenesis of psoriasis involving the IFNα-TNFα-IL-23-IL-17 pathway suggests that the elevated levels of IFNα in severe psoriasis cases might be further increased by TNF inhibitors, potentially heightening the risk of autoantibody production. The gene discussed is TNF; the disease is psoriasis.